Metformax 850

Metformin Hydrochloride, the active ingredient in Metformax 850, is a biguanide presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to lower elevated blood glucose levels by improving the body’s response to insulin.

GNH USA supplies Metformax 850 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Metformax 850 (metformin) is used in the treatment of disorders related to impaired glucose regulation.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformax 850 may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea. - Metallic taste. - Flatulence. - Mild weight loss.

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal accumulation of lactate. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic failure or significant elevation of liver enzymes.

When prescribing Metformax 850, several safety considerations should be observed.

Renal function assessment: evaluate creatinine clearance before initiating therapy. Hepatic function monitoring: avoid use in patients with active liver disease. Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia. Elderly patients: start at lower dose and monitor tolerance. Concomitant medication review: assess for drugs that may increase metformin levels. Store at room temperature: keep in the original container, protect from moisture and heat.

Metformax 850 can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; suspend metformin before and after imaging. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium. - Oral contraceptives: may modestly raise metformin levels. - Corticosteroids: may increase blood glucose, requiring dose adjustment.